ARCHITECT HE4 02P54-25

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05,foreign,health professi report with the FDA on 2015-06-24 for ARCHITECT HE4 02P54-25 manufactured by Abbott Germany.

Event Text Entries

[20038829] The customer stated that a falsely decreased architect he4 result of 33. 2 pmol/l was generated for a patient with a ca 125 result of 433. 1 u/ml and 3. 6% roma (risk of ovarian malignancy algorithm) on (b)(6) 2015. This testing was performed because a pelvic mass was found in the patient's sonography report. Surgery was performed on (b)(6) 2015 and the histopathological diagnosis revealed serious carcinoma of the ovary. The post-surgical roma was 49. 8%. A post-surgical he4 result was not provided. No adverse impact to patient management was reported.
Patient Sequence No: 1, Text Type: D, B5


[20427770] An evaluation is in process. A follow-up report will be submitted when the evaluation is complete. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[26124610] This follow-up emdr is being submitted to correct the product code. Suspect medical device. The correct product code for this medical device, architect (b)(4). An evaluation is in process. A follow-up report will be submitted when the device evaluation is complete.
Patient Sequence No: 1, Text Type: N, H10


[33001187] Review of ticket trending and lot search data did not identify an increase in complaint activity related to discrepant patient results. Accuracy testing was completed using retained kits of reagent lot 42042m500. Acceptance criteria was met, which indicates acceptable product performance. A deficiency was not identified as accuracy testing shows that the assay performs per specification. No malfunction was identified since the issue involves one discreet patient and the sensitivity for stratifying patients with stage i-iv epithelial ovarian cancer into the high risk group is 93% at a specificity of 75%. Additionally, the limitations of the procedure and expected values section of the architect he4 package insert addresses the customer's issue.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3002809144-2015-00043
MDR Report Key4866822
Report Source01,05,FOREIGN,HEALTH PROFESSI
Date Received2015-06-24
Date of Report2015-08-20
Date of Event2015-05-07
Date Mfgr Received2015-08-14
Device Manufacturer Date2014-09-01
Date Added to Maude2015-07-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224667-512
Manufacturer G1ABBOTT GERMANY
Manufacturer StreetMAX-PLANCK-RING 2
Manufacturer CityWIESBADEN 65205
Manufacturer CountryGM
Manufacturer Postal Code65205
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameARCHITECT HE4
Generic NameHE4
Product CodeOIU
Date Received2015-06-24
Catalog Number02P54-25
Lot Number42042M500
Device Expiration Date2015-08-06
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT GERMANY
Manufacturer AddressMAX-PLANCK-RING 2 WIESBADEN 65205 GM 65205


Patients

Patient NumberTreatmentOutcomeDate
10 2015-06-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.